Intramyocardial transplantation of bone marrow-derived stem cells is a potential therapeutic option after myocardial infarction (MI). Intramyocardial administration is invasive but allows efficient and targeted stem cell delivery. Aims of this study were validation of minimal-invasive, echo-guided closed-chest cell transplantation (CTx) of mononuclear (MNC) or mesenchymal stem cells (MSC) and quantification of systolic left ventricular function and assessment of contractile reserve with high-resolution reconstructive 3D-echocardiography (r3D-echo) 3 weeks after CTx. Female Fischer344 rats received syngeneic male MNC, MSC, or medium after myocardial ischemia and reperfusion via echo-guided percutaneous injection (open-chest for control). Left ventricular systolic function was measured and dysfunctional myocardium was quantified with r3D-echo. For investigation of contractile reserve and myocardial viability r3D-echo was additionally conducted during low-dose dobutamine 3 weeks after CTx. Cell persistence after echo-guided CTx was quantified via real-time PCR; scar size was measured histologically. Echo-guided percutaneous CTx was feasible in all animals (n = 30) without periprocedural complications. After 3 weeks, 1.4 ± 1.1% of transplanted MNC and 1.9 ± 1.2% of MSC were detected. These numbers were comparable to those after openchest intramyocardial injection of MNC (0.8 ± 1.1%; n = 8, p = 0.3). In r3D-echo no functional benefit was associated with CTx after MI and reperfusion. All groups (MNC, MSC, and controls) revealed a significant decrease of dysfunctional myocardium and similar contractile reserve during inotropic stimulation.In conclusion, percutaneous echo-guided closed-chest CTx promises to be an effective and safe approach for CTx in small-animal research. However, intramyocardial CTx of MNC or MSC had no influence on systolic function and contractile reserve after reperfused MI.
INTRODUCTION
after myocardial infarction (20) , despite the low persistence of injected cells (8, 24) . On the other hand, other well-performed studies revealed less favorable results Intramyocardial cell transplantation (CTx) of bone marrow cells (BMC) has been under investigation for (12) . While intracoronary CTx can be performed via coronary catheter, which is less invasive than myocar-the treatment of acute myocardial infarction for several years. Therefore, subpopulations, such as mononuclear dial injection, the intravascular mode of delivery is less effective (24) and does not allow targeting of cell deliv-stem cells (MNC) and mesenchymal stem cells (MSC), have been investigated to assess their functional impact. ery into distinct dysfunctional myocardial segments. Therefore, novel strategies of targeted CTx that are less The largest randomized, placebo-controlled study to date demonstrated beneficial effects of intracoronary cell invasive than open-chest surgery are of major interest. Despite the advance of CTx with BMC to the clinical therapy on left ventricular ejection fraction in patients level, further animal studies are needed to estimate its costal space and a 7-0 polypropylene suture was placed around the left anterior descending artery (LAD). Both therapeutic effect, as well as to identify the most suitable cell type. Therapeutic goals should not only aim at ends of the suture were led through a short plastic tube, forming a loose snare around the LAD. Each end of the global and regional left ventricular function, but also on the amount of dysfunctional myocardium and contractile suture was externalized laterally through each side of the thorax and placed under the skin. Then the chest was reserve demonstrating myocardial viability. Furthermore, because first-line therapy of acute myocardial ischemia closed layer by layer. Tramadol and carprofen were given subcutaneously (40 mg/kg/24 h and 5 mg/kg/24 is revascularization with consecutive reperfusion, animal models should implement this primary treatment strat-h, respectively) as postoperative analgetics.
To avoid stress-induced immunological response to egy in the experimental protocol for evaluation of impact of CTx on myocardial dysfunction. In the present the thoracotomy, acute myocardial ischemia was induced 7 days after the initial operation by occlusion of study we performed sonographically guided minimalinvasive myocardial closed-chest BMC-CTx. The im-the LAD (17). The ends of the suture were externalized from the skin pouches, carefully taped to heavy metal pact of two distinct BMC populations (MNC or MSC) on global and regional left ventricular systolic function picks, and pulled apart carefully for 60 min. Acute myocardial ischemia was controlled by means of electro-and was assessed with reconstructive 3D-echocardiography (r3D-echo). Further, the impact of BMC-CTx on the echocardiography, resulting in elevation of ST segment and regional dysfunction of anterolateral wall segments, quantity of dysfunctional myocardium and contractile reserve was assessed in rats after acute myocardial in-respectively. farction with reperfusion.
Transplantation of BMC MATERIALS AND METHODS
Minimal-invasive BMC-CTx was performed immediately after myocardial ischemia and reperfusion. After 1 Experimental protocol was approved by the regional government's Animal Care and Use Committee (50.203.2-h the coronary occlusion was released and blood flow was reestablished. Subsequently, rats were randomized K 47, 34/03), and conformed to the Guide for the Care and Use of Laboratory Animals (NIH publication No.
to receive myocardial injections of either MNC, MSC, or medium. During continuous echocardiographic guid-85-23, National Academy Press, Washington DC, revised 1996) (2).
ance, 60 µl of cell suspension was injected percutaneously into three separate sites of the anterior, lateral, and Cell Isolation posterior myocardial peri-infarction border zone. This procedure was performed using a 100-µl Hamilton sy-The femurs, humeral, and tibial bones (male Fi-scher344 rats, 2 months old, Charles River Laboratories, ringe attached to a 30-gauge needle. Efficacy of intramyocardial cell delivery was monitored sonographically Sulzfeld, Germany) were dissected as described previously (13) . Bone marrow was eluted with a 19-gauge after the intervention ( Fig. 1 ). Open-chest CTx of MNC was conducted similarly into peri-infarction border zone needle and DMEM, high glucose, 10% FCS, 1% penicillin/streptomycin. The cell suspension was filtered myocardium as described recently (13) . through 70-µm filters, centrifuged, and resuspended in Reconstructive 3D-Echocardiography PBS. A ficoll gradient centrifugation (NycoPrep, Progen GmbH, Heidelberg, Germany) was performed and the For high-resolution r3D-echo a HDI-5000 ultrasound system (HDI-5000, Philips Medical Systems, The Neth-MNC were collected and washed three times with PBS. For isolation of MSC 50 × 10 6 of the remaining cells erlands) was used, equipped with a 15 MHz linear array transducer allowing frame rates of up to 230 Hz making were plated on 10-cm dishes, and nonadherent cells were removed after 72 h. MSC were expanded to pas-use of harmonic imaging (4,23). The transducer was positioned perpendicular to the long axis of the left ventri-sage 3 and then detached with trypsin/EDTA. The cells were centrifuged at 800 × g for 1 min and resuspended cle in consecutive short-axis sections starting at the aortic root. ECG and respiratory gated imaging was in serum-free DMEM medium at a concentration of 10 6 cells/60 µl. Cell viability was 90.0 ± 2.1% as assessed performed in 12-18 consecutive short-axis views of 0.5mm increment (Fig. 2) . Cineloops of 2-s duration were by trypan blue staining before cell injection.
stored digitally for each short-axis view and analyzed Rat Model of Acute Myocardial Infarction offline. Additionally, the imaging protocol was repeated during intravenous low-dose dobutamine infusion for as-For the induction of myocardial infarction, female Fischer 344 rats (125-150 g) were anesthetized with 1.0-sessment of myocardial viability (10 µg/kg/min) (6). r3D-echo was performed during myocardial ischemia 1.5% isoflurane, intubated, and ventilated as previously described (6) . The thorax was opened via the third inter-and 3 weeks after reperfusion by one investigator blinded to treatment groups. For echocardiography, rats dial surfaces, circumferential sections were multiplied with the intersection interval (0.5 mm) and summarized were anesthetized with 1.0-1.2% isoflurane in O 2 , minimizing cardiodepressant effects (22).
along the long axis, as validated previously (6). Myocardial compartments were differentiated by vi-All imaging planes from basal to apical were visually assessed for: 1) left ventricular wall motion, 2) wall sual assessment following established echocardiographic criteria: a) akinetic/dyskinetic wall motion (collagenous thickness and systolic wall thickening, 3) echocardiographic criteria of scar formation (increased echodensity scar): thinned, echodense wall, no systolic wall thickening, no inotropic response to dobutamine; b) hypokinetic and wall thinning), and 4) contractile reserve. In addition, quantitative assessment was performed. Therefore, wall motion (peri-infarction border zone myocardium): normal myocardial thickness, markedly reduced systolic based on visual judgment, circumferential sections were placed to define: a) epicardial circumference, b) endo-wall thickening during baseline, reduced inotropic response to dobutamine; c) normokinetic wall motion (re-cardial circumference, c) akinetic circumference, d) septal hypokinetic circumference, and e) lateral hypokinetic mote myocardium): normal myocardial thickness, good systolic wall thickening, good inotropic response to do-circumference in each plane at end-diastole ( Fig. 2) . Additionally, epi-and endocardial regions of interest butamine. as described previously (14) . Samples with known dilu-Statistical Analysis tions of male with female DNA were included to verify All analyses were performed blinded to randomizaconsistency and to derive a calibration curve for the caltion. Data were presented as mean ± SD. GraphPad culation of male/total ratio. DNA (1 µg) was used for InStat was used for computerized statistical analysis the analysis, and we were able to detect 1 male cell in applying one-way ANOVA and post-hoc Tukey test be-100,000 cells.
tween the groups. Differences were considered significant if p < 0.05. Histology RESULTS Animals were euthanized after the last echocardiographic evaluation; the hearts were excised and placed A total of 55 animals underwent primary surgery; in 4% paraformaldehyde for 24 h and washed in PBS.
eight died shortly after surgery, five during infarct in-Then they were cryoprotected in 18% sucrose and fiduction due to extensive ischemic area, and in four cases nally embedded with Tissue Tec and stored at −80°C.
ischemia could not be induced, so that 38 animals were To investigate scar size and collagen deposition cryosecsubject to analysis (n = 10 for each MNC, MSC, and tions (5 µm) were stained with Masson's trichrome in medium; n = 8 for open-chest control). intervals of 250 µm from base to apex. The sections Safety and Efficacy of Minimal-Invasive, Echo-Guided were scanned and the infarction areas planimetrically
Closed-Chest CTx analyzed using Sigmascan Pro 5.0 (Software SigmaScan Pro, Image Analysis, Version 5.0.0, SPSS Science, Ger-During the intramyocardial injection the development of an echo-dense intramyocardial deposit was recog-many). The volumes of infarcted and noninfarcted myocardium were calculated from planimetric analysis using nized in all injection sites of all animals (3 sites × 30 animal/3 sites × 30 animals). Three weeks after the in-modified Simpson's method. jection of 10 6 MNC, 1.4 ± 1.1% of initially injected cells difference in left ventricular volumes between the groups evolved (Table 1) . Similarly, the global systolic were detected (corresponding to 14,100 cells). Similar engraftment efficacy was found for 10 6 MSC, namely function was not different in animals treated with MNC (LVEF 53 ± 3%), MNC open-chest (52 ± 5%) as in ani-1.9 ± 1.2% (i.e. 18,800 cells) and for open-chest CTx (0.8 ± 1.1%, i.e. 8,400 cells; p = 0.3). mals treated with MSC (50 ± 5%) and in control animals (60 ± 4%). If anything, there was trend towards higher r3D-Echo After Percutaneous Bone Marrow LVEF in control animals (Fig. 3 ). Stroke volume (SV) Cell Therapy revealed no significant differences between the groups with a trend to increased SV in the control animals (Ta-Left ventricular end-diastolic and end-systolic volumes revealed no significant differences between the ble 2). Stress echocardiography revealed a preserved dobutamine-induced increment in ejection fraction, reflect-groups (Table 1) . Global left ventricular ejection fraction (LVEF) after 1 h of ischemia was reduced to similar ing a contractile reserve and preserved myocardial viability, in the treated groups after CTx, which however levels in all groups (Fig. 3) . Three weeks after CTx no was not higher than that of the medium group (Table 2) . fected by bone marrow cell therapy in this model of infarction and reperfusion.
Interestingly, the individual amount and absolute number of surviving bone marrow cells found after 3 weeks
In contrast, previous results from animal experiments showed a wide discrepancy in heart function improve-was neither associated with global and regional left ventricular function nor with the amount of dysfunctional ment from significant increase of LVEF to marginal level of recovery after BMC-CTx. Orlic et al. were the myocardium.
To further evaluate the effect of cell therapy we ex-first to describe functional benefit after myocardial infarction and the injection of specifically selected bone amined the absolute and relative myocardial surface of dysfunctional, hypokinetic, and akinetic myocardium. marrow cells (18) . The functional benefit of this procedure was confirmed by many studies using different Further regional analysis revealed no significant differences between the four groups. The surface of akinetic kinds of bone marrow cells, although the mode of action of bone marrow cell therapy remains a matter of debate and hypokinetic myocardium at resting conditions as well as after inotropic stimulation decreased in all (7, 15, 19) . Other studies found a transient benefit that was no longer detectable at later times (3). Meanwhile, groups to similar levels, suggesting persistent dysfunction of left ventricular myocardium, which is not influ-there is a handful of well-performed randomized doubleblind clinical studies that have assessed the functional enced by cell therapy with MNC or MSC. Consistently, the recruitment of dysfunctional, but viable myocardium impact of mononuclear cells after acute myocardial infarction. The results are controversial. While the largest that is reflected in the dobutamine-related reduction of dysfunctional myocardium did not reveal differences be-study detected clear functional benefit for patients treated with bone marrow cells compared to controls tween groups (Fig. 4) . (20) , two other studies found no influence of bone mar-Histology row cell therapy on global myocardial function (9, 12) . Therefore, in spite of the many studies that were per-The size of the collagenous scar as quantified by histomorphometry was not significantly changed 3 weeks formed to date on bone marrow cell therapy after myocardial infarction, there is need for further information after CTx (Fig. 5) . and additional investigations, which might be able to DISCUSSION shed light onto this controversial issue.
In the present study no difference between groups In the present study, the validation of minimal invasive, percutaneous echo-guided closed-chest cell trans-(MNC, MSC, and control) was found for either the global systolic function measured as LVEF or the re-plantation (CTx) of mononuclear (MNC) or mesenchymal stem cells (MSC) and the functional impact of such gional function quantified as dysfunctional myocardium. One obvious reason for our sobering results may be that therapy were studied in a rat model of myocardial infarction and reperfusion. The main findings were that the specific experimental setup with infarction/reperfusion and cell injection immediately after reperfusion is the new mode of cell delivery was comparably safe, feasible, and effective as the invasive approach. However, just not suitable to demonstrate the therapeutic effect of bone marrow cells. Thus, in the clinical setting there is neither left ventricular dimensions were decreased nor global LVEF was increased 3 weeks after CTx com-some evidence that timing of cell injection should be a few days after infarction and reperfusion (20) . More-pared to controls. Quantity of dysfunctional myocardium (as assessed with r3D-echo) and size of infarct scar (as over, in most preclinical small-animal studies permanent coronary artery ligation was used, which may be the pre-assessed by histology) as well as assessment of contractile reserve after inotropic stimulation remained unaf-ferred condition for bone marrow cells to exert their beneficial therapeutic effect (3). The notion that ische-perfused myocardial infarcts than in animals with permanent vessel occlusion, which may serve as one reason mia/reperfusion, albeit clinically relevant, may not be ideal to demonstrate the beneficial effect of bone mar-for lack of effectiveness in ischemia/reperfusion (11) . In the present study, however, cell persistence was mea-row cell therapy is supported by the partly negative results of the clinical studies. Along that line, we observed sured and resulted in 1-2% of initially injected cells at 3 weeks, which is a similar number as previously ob-that cell persistence was lower in rats and pigs with reserved in permanently ligated rat hearts after open-chest CTx (13) . Because we do not know the optimal settings, optimal timings, and optimal cell types for cell therapy, it will not be possible to rule out that the experimental setup chosen for this study was suboptimal to demonstrate the efficacy of bone marrow cell therapy for myocardial infarction. Nevertheless, the current study has several important strengths in the methodologies chosen, which may render some special impact to the data that were obtained. First, to obtain comparable systolic impairment for reproducible determination of therapeutic impact, left ventricular systolic function and extent of dysfunctional myocardium was measured before CTx. Only those animals were included in the study that showed similar impairment of global left ventricular systolic function and wall motion abnormalities. This selection lead to a rather low variability of infarct sizes while still allowing us to use a technique that mimics the pathophysiological animals, but similar to the clinical situation, reperfusion of the myocardial infarct was allowed (1). The closed-dial viability with r3D-echo after CTx. This method allows valid quantification of regional myocardial dys-chest model of temporary left coronary artery occlusion in rats used in this study is novel and rarely applied function and global contractile reserve. Furthermore, r3D-echo allows precise differentiation of vital myocar-in experimental BMC-CTx. This approach offers good resemblance with the clinical situation when patients dial border zone and identification of nonvital transmural scar tissue noninvasively (6) . Ultimately, inotropic with acute myocardial infarction undergo early PCI to achieve prompt revascularisation and reperfusion. stimulation exposed no disguised regional and global left ventricular functional improvement of reperfused Thereby, it allows investigation of the effect of CTx in addition to the beneficial effect of reperfusion therapy. but dysfunctional myocardium in animals after BMC-CTx. Furthermore, thoracotomy induces cytokine expression, which may influence the results of small-animal studies
In conclusion, we found that closed-chest intramyocardial injection of BMCs is as effective as open-chest in which infarct induction and cell injection are performed during open thorax surgery (17). Therefore, injection with comparable (but low) cell persistence at 3 weeks after transplantation. At this distinct time point ischemia and reperfusion as well as cell injection are performed one week after suture placement during tho-after transplantation, we did observe neither deceleration of left ventricular dilatation nor improvement of the racotomy reducing the confounding factor of major surgery. Thirdly, interventional percutaneous cell injection global and regional systolic function. Infarct size as assessed by echocardiography and histomorphometry also was performed during echocardiographic control, which allowed to assess successful injections, and which al-remained unchanged. The results support the notion that the therapeutic efficacy of bone marrow cell therapy lowed visualization of the needle to guide the injections exactly into the functionally impaired myocardial peri-after myocardial infarction may be limited and may depend on very distinct conditions that apparently were not infarction border zone. This procedure was performed for the first time by Springer et al. (21) . Their quantita-chosen in the present study. The closed-chest echoguided percutaneous technique of cell injection may be tive dye injection studies in mouse hearts demonstrated that guided closed-chest injections and open-chest injec-particularly useful for repeated and/or sequential cell applications after myocardial infarction. tions deliver comparable amounts of injectate and prevents erroneous cell injections into the left ventricular ACKNOWLEDGMENTS: A.G. was supported by the German cavity. Here, we were able to detect an ultrasound-opaque 
